Date:3/14/2013

The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results and actual events may differ significantly from those suggested or indicated in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, the market price of the Company's stock prevailing from time to time, the nature of other investment opportunities presented to the Company from time to time, the Company's cash flow from operations, general economic conditions and other factors discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2012 as filed with the SEC on February 4, 2013, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

CONTACTS:	James Winschel, Senior Vice President and Chief Financial Officer
	Jill Baker, Corporate Vice President of Investor Relations
	+1-781-434-4118

'/>"/>

SOURCE PAREXEL International Corporation Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference
2. PAREXEL International To Present At Citi Global Healthcare Conference
3. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
4. PAREXEL International To Present At Oppenheimer Healthcare Conference
5. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
6. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
7. PAREXEL International to Present at Robert Baird Healthcare Conference
8. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
9. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
10. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
11. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call